Myriad Genetics | MYGN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.81B 49M 2026-03
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Danaher USD 4.35B 1.35B 2026-06
Illumina USD 1.09B 329M 2026-03
J&J USD 20.42B 1.27B 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
OraSure Technologies USD 160.58M 16.38M 2026-06
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Quest Diagnostics USD 626M 233M 2026-06
Quidel USD 123.4M 17M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 299.52M 36.38M 2026-06
Waters USD 539M 77M 2026-06